| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |